Weimou Biotechnology Co., Ltd focuses on the research and development of innovative drugs for the treatment of ophthalmic diseases, and is committed to providing treatment solutions for patients with these conditions. The company has a product pipeline and an international team.

Weimou Biotechnology Co., Ltd

Viva BioInnovator operates as the investment division of Viva Biotech Holdings, focusing on identifying and supporting early-stage biotech companies through investment and incubation.

Viva BioInnovator

VivaVision Biotech, Inc. | 107 followers on LinkedIn. 维眸生物是专注于眼科治疗领域的创新药公司，致力于为千百万眼科疾病患者提供更好更优的治疗方案。公司由国际一流的眼科创新药研发专家组建，已经建立起独特的眼科创新药研发平台。公司自主开发的多个产品即将进入临床阶段。

Metric
Company Name	Weimou Biotechnology Co., Ltd	Viva BioInnovator
Symbol
MSH ID	COM:VIVAVISIONBIO	COM:VIVABIOINNOVATOR
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Financial Services & Finance
Industry	Pharmaceuticals	Biotechnology
Country	CN	HK
Stage	Series D
Employee Count
Website	vivavisionbio.com/en	vivabioinnovator.com
LinkedIn	%E7%BB%B4%E7%9C%B8%E7%94%9F%E7%89%A9	viva-bioinnovator
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	158	176
Web Traffic Growth	-0.52	-0.72
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

VIVA

COM:VIVAVISIONBIO

Weimou Biotechnology Co., Ltd

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue